Adventures in vascular biology: a tale of two mediators.

Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences
Salvador Moncada

Abstract

I would like to thank the Royal Society for inviting me to deliver the Croonian Lecture. In so doing, the Society is adding my name to a list of very distinguished scientists who, since 1738, have preceded me in this task. This is, indeed, a great honour. For most of my research career my main interest has been the understanding of the normal functioning of the blood vessel wall and the way this is affected in pathology. During this time, our knowledge of these subjects has grown to such an extent that many people now believe that the conquering of vascular disease is a real possibility in the foreseeable future. My lecture concerns the discovery of two substances, prostacyclin and nitric oxide. I would like to describe the moments of insight and some of the critical experiments that contributed significantly to the uncovering of their roles in vascular biology. The process was often adventurous, hence the title of this lecture. It is the excitement of the adventure that I would like to convey in the text that follows.

References

Dec 1, 1976·Prostaglandins·N WhittakerF F Sun
Jul 1, 1979·Physiological Reviews·B ChanceA Boveris
Oct 7, 1978·Lancet·J O'Grady, S Moncada
Oct 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·J W BurchP W Majerus
Jun 15, 1979·Biochemical Pharmacology·G A HiggsJ R Vane
Jan 1, 1979·Haemostasis·S Moncada, J L Amezcua
Feb 1, 1978·The Journal of Clinical Investigation·J W BurchP W Majerus
Apr 1, 1977·Prostaglandins·S MoncadaP Needleman
Jan 1, 1975·Annual Review of Biochemistry·B SamuelssonS Hammarström
Aug 1, 1975·Proceedings of the National Academy of Sciences of the United States of America·M HambergB Samuelsson
Sep 1, 1975·The Journal of Clinical Investigation·G J Roth, P W Majerus
Jun 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·P KubesD N Granger
Dec 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·K M DesaiJ R Vane
Aug 1, 1991·European Journal of Clinical Investigation·S Moncada, E A Higgs
Apr 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·W L XieD L Simmons
Feb 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·J S BeckmanB A Freeman
Jul 31, 1990·Biochemical and Biophysical Research Communications·L J IgnarroJ Rajfer
May 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·D D ReesS Moncada
Oct 17, 1989·European Journal of Pharmacology·J GarthwaiteS Moncada
Dec 1, 1989·Clinical and Experimental Pharmacology & Physiology·C G Li, M J Rand
Jul 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·R G KnowlesS Moncada

❮ Previous
Next ❯

Citations

Apr 13, 2011·Purinergic Signalling·Hillary A Johnston-Cox, Katya Ravid
Jul 1, 2010·Cardiovascular Intervention and Therapeutics·Qiang FuTakaaki Isshiki
Nov 26, 2008·Nature Clinical Practice. Cardiovascular Medicine·Peter F Davies
Dec 14, 2007·The New England Journal of Medicine·Giovanni Davì, Carlo Patrono
Aug 24, 2010·Journal of Medicinal Food·Byung Hee KimBoo-Yong Lee
Apr 13, 2013·Cardiovascular Research·Imo E HoeferMat J A P Daemen
Aug 3, 2011·Clinical and Experimental Pharmacology & Physiology·Luisa R de MeirellesTatiana M C Brunini
Oct 7, 2008·Annual Review of Pharmacology and Toxicology·Geoffrey Burnstock
Jun 9, 2007·The Journal of Clinical Investigation·Dmitriy N AtochinPaul L Huang
Feb 8, 2014·Canadian Journal of Physiology and Pharmacology·Douglas L Jones
Apr 11, 2013·International Journal of Hypertension·Yolanda MendizábalEduardo Nava
Jun 12, 2012·Trends in Cardiovascular Medicine·Kel Vin Woo, H Scott Baldwin
Jun 16, 2010·Pharmacology & Therapeutics·Dimitris TousoulisChristodoulos Stefanadis
Nov 27, 2007·Progress in Neurobiology·F FlorenzanoM Molinari
Jul 21, 2012·Trends in Cardiovascular Medicine·Bilal AtayaBrian S Zuckerbraun
Oct 21, 2016·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Eduardo Nava, Silvia Llorens
Jan 27, 2017·BMC Cell Biology·Daniela BegandtXavier F Figueroa
Dec 15, 2017·Medicine and Science in Sports and Exercise·Andrew HaynesDaniel J Green
Mar 23, 2011·Journal of the Renin-angiotensin-aldosterone System : JRAAS·Payal BhallaKrishnan Ravi
Aug 29, 2009·Arteriosclerosis, Thrombosis, and Vascular Biology·Cormac T Taylor, Salvador Moncada
Aug 19, 2007·Journal of Cardiovascular Pharmacology·Maleka P Hashmi-HillStephen J Lewis
Aug 19, 2007·Journal of Cardiovascular Pharmacology·Byung Hee KimCasimir C Akoh
Jan 4, 2012·Journal of Cellular Physiology·Anna A BirukovaKonstantin G Birukov
Nov 14, 2019·British Journal of Pharmacology·Y S Bakhle
Apr 28, 2011·Cancer·Mary-Clare CathcartKenneth J O'Byrne
Jul 29, 2015·Current Opinion in Lipidology·Juhyun LeeTzung K Hsiai
Aug 21, 2007·Essays in Biochemistry·Alexander GalkinSalvador Moncada
Feb 23, 2013·Journal of Cardiovascular Pharmacology·Hui-Bin LiuZhi-Ren Zhang
Feb 8, 2021·Nutrition, Metabolism, and Cardiovascular Diseases : NMCD·Matteo NardinGiuseppe De Luca
Sep 17, 2021·Molecular and Cellular Biochemistry·Rahul Mallick, Asim K Duttaroy
Oct 2, 2009·Revista española de cardiología·Lina BadimónTeresa Padró

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.